Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF)...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Gui, Xianhua [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: International immunopharmacology - Laupland, Kevin B. ELSEVIER, 2022, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:70 ; year:2019 ; pages:208-215 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.intimp.2019.02.039 |
|---|
| Katalog-ID: |
ELV046273611 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV046273611 | ||
| 003 | DE-627 | ||
| 005 | 20230624122419.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191021s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.intimp.2019.02.039 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000607.pica |
| 035 | |a (DE-627)ELV046273611 | ||
| 035 | |a (ELSEVIER)S1567-5769(18)31455-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.75 |2 bkl | ||
| 100 | 1 | |a Gui, Xianhua |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis |
| 264 | 1 | |c 2019 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. | ||
| 700 | 1 | |a Qiu, Xiaohua |4 oth | |
| 700 | 1 | |a Tian, Yaqiong |4 oth | |
| 700 | 1 | |a Xie, Miaomiao |4 oth | |
| 700 | 1 | |a Li, Hui |4 oth | |
| 700 | 1 | |a Gao, Yujuan |4 oth | |
| 700 | 1 | |a Zhuang, Yi |4 oth | |
| 700 | 1 | |a Cao, Mengshu |4 oth | |
| 700 | 1 | |a Ding, Hui |4 oth | |
| 700 | 1 | |a Ding, Jingjing |4 oth | |
| 700 | 1 | |a Zhang, Yingwei |4 oth | |
| 700 | 1 | |a Cai, Hourong |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Laupland, Kevin B. ELSEVIER |t International immunopharmacology |d 2022 |g Amsterdam [u.a.] |w (DE-627)ELV00785823X |
| 773 | 1 | 8 | |g volume:70 |g year:2019 |g pages:208-215 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.intimp.2019.02.039 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.75 |j Infektionskrankheiten |j parasitäre Krankheiten |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 70 |j 2019 |h 208-215 |g 8 | ||
| author_variant |
x g xg |
|---|---|
| matchkey_str |
guixianhuaqiuxiaohuatianyaqiongxiemiaomi:2019----:rgotcauoinc13c2ncc1ivleiauexcrainf |
| hierarchy_sort_str |
2019 |
| bklnumber |
44.75 |
| publishDate |
2019 |
| allfields |
10.1016/j.intimp.2019.02.039 doi GBV00000000000607.pica (DE-627)ELV046273611 (ELSEVIER)S1567-5769(18)31455-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Gui, Xianhua verfasserin aut Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. Qiu, Xiaohua oth Tian, Yaqiong oth Xie, Miaomiao oth Li, Hui oth Gao, Yujuan oth Zhuang, Yi oth Cao, Mengshu oth Ding, Hui oth Ding, Jingjing oth Zhang, Yingwei oth Cai, Hourong oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:70 year:2019 pages:208-215 extent:8 https://doi.org/10.1016/j.intimp.2019.02.039 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 70 2019 208-215 8 |
| spelling |
10.1016/j.intimp.2019.02.039 doi GBV00000000000607.pica (DE-627)ELV046273611 (ELSEVIER)S1567-5769(18)31455-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Gui, Xianhua verfasserin aut Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. Qiu, Xiaohua oth Tian, Yaqiong oth Xie, Miaomiao oth Li, Hui oth Gao, Yujuan oth Zhuang, Yi oth Cao, Mengshu oth Ding, Hui oth Ding, Jingjing oth Zhang, Yingwei oth Cai, Hourong oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:70 year:2019 pages:208-215 extent:8 https://doi.org/10.1016/j.intimp.2019.02.039 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 70 2019 208-215 8 |
| allfields_unstemmed |
10.1016/j.intimp.2019.02.039 doi GBV00000000000607.pica (DE-627)ELV046273611 (ELSEVIER)S1567-5769(18)31455-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Gui, Xianhua verfasserin aut Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. Qiu, Xiaohua oth Tian, Yaqiong oth Xie, Miaomiao oth Li, Hui oth Gao, Yujuan oth Zhuang, Yi oth Cao, Mengshu oth Ding, Hui oth Ding, Jingjing oth Zhang, Yingwei oth Cai, Hourong oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:70 year:2019 pages:208-215 extent:8 https://doi.org/10.1016/j.intimp.2019.02.039 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 70 2019 208-215 8 |
| allfieldsGer |
10.1016/j.intimp.2019.02.039 doi GBV00000000000607.pica (DE-627)ELV046273611 (ELSEVIER)S1567-5769(18)31455-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Gui, Xianhua verfasserin aut Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. Qiu, Xiaohua oth Tian, Yaqiong oth Xie, Miaomiao oth Li, Hui oth Gao, Yujuan oth Zhuang, Yi oth Cao, Mengshu oth Ding, Hui oth Ding, Jingjing oth Zhang, Yingwei oth Cai, Hourong oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:70 year:2019 pages:208-215 extent:8 https://doi.org/10.1016/j.intimp.2019.02.039 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 70 2019 208-215 8 |
| allfieldsSound |
10.1016/j.intimp.2019.02.039 doi GBV00000000000607.pica (DE-627)ELV046273611 (ELSEVIER)S1567-5769(18)31455-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Gui, Xianhua verfasserin aut Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. Qiu, Xiaohua oth Tian, Yaqiong oth Xie, Miaomiao oth Li, Hui oth Gao, Yujuan oth Zhuang, Yi oth Cao, Mengshu oth Ding, Hui oth Ding, Jingjing oth Zhang, Yingwei oth Cai, Hourong oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:70 year:2019 pages:208-215 extent:8 https://doi.org/10.1016/j.intimp.2019.02.039 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 70 2019 208-215 8 |
| language |
English |
| source |
Enthalten in International immunopharmacology Amsterdam [u.a.] volume:70 year:2019 pages:208-215 extent:8 |
| sourceStr |
Enthalten in International immunopharmacology Amsterdam [u.a.] volume:70 year:2019 pages:208-215 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Infektionskrankheiten parasitäre Krankheiten |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
International immunopharmacology |
| authorswithroles_txt_mv |
Gui, Xianhua @@aut@@ Qiu, Xiaohua @@oth@@ Tian, Yaqiong @@oth@@ Xie, Miaomiao @@oth@@ Li, Hui @@oth@@ Gao, Yujuan @@oth@@ Zhuang, Yi @@oth@@ Cao, Mengshu @@oth@@ Ding, Hui @@oth@@ Ding, Jingjing @@oth@@ Zhang, Yingwei @@oth@@ Cai, Hourong @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00785823X |
| dewey-sort |
3610 |
| id |
ELV046273611 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV046273611</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624122419.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.intimp.2019.02.039</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000607.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV046273611</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1567-5769(18)31455-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gui, Xianhua</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qiu, Xiaohua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tian, Yaqiong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xie, Miaomiao</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Hui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gao, Yujuan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhuang, Yi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cao, Mengshu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ding, Hui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ding, Jingjing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Yingwei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cai, Hourong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Laupland, Kevin B. ELSEVIER</subfield><subfield code="t">International immunopharmacology</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00785823X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:70</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:208-215</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.intimp.2019.02.039</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.75</subfield><subfield code="j">Infektionskrankheiten</subfield><subfield code="j">parasitäre Krankheiten</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">70</subfield><subfield code="j">2019</subfield><subfield code="h">208-215</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Gui, Xianhua |
| spellingShingle |
Gui, Xianhua ddc 610 bkl 44.75 Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis |
| authorStr |
Gui, Xianhua |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00785823X |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.75 bkl Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis |
| topic |
ddc 610 bkl 44.75 |
| topic_unstemmed |
ddc 610 bkl 44.75 |
| topic_browse |
ddc 610 bkl 44.75 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
x q xq y t yt m x mx h l hl y g yg y z yz m c mc h d hd j d jd y z yz h c hc |
| hierarchy_parent_title |
International immunopharmacology |
| hierarchy_parent_id |
ELV00785823X |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
International immunopharmacology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00785823X |
| title |
Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis |
| ctrlnum |
(DE-627)ELV046273611 (ELSEVIER)S1567-5769(18)31455-3 |
| title_full |
Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis |
| author_sort |
Gui, Xianhua |
| journal |
International immunopharmacology |
| journalStr |
International immunopharmacology |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
208 |
| author_browse |
Gui, Xianhua |
| container_volume |
70 |
| physical |
8 |
| class |
610 VZ 44.75 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Gui, Xianhua |
| doi_str_mv |
10.1016/j.intimp.2019.02.039 |
| dewey-full |
610 |
| title_sort |
prognostic value of ifn-γ, scd163, ccl2 and cxcl10 involved in acute exacerbation of idiopathic pulmonary fibrosis |
| title_auth |
Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis |
| abstract |
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. |
| abstractGer |
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. |
| abstract_unstemmed |
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis |
| url |
https://doi.org/10.1016/j.intimp.2019.02.039 |
| remote_bool |
true |
| author2 |
Qiu, Xiaohua Tian, Yaqiong Xie, Miaomiao Li, Hui Gao, Yujuan Zhuang, Yi Cao, Mengshu Ding, Hui Ding, Jingjing Zhang, Yingwei Cai, Hourong |
| author2Str |
Qiu, Xiaohua Tian, Yaqiong Xie, Miaomiao Li, Hui Gao, Yujuan Zhuang, Yi Cao, Mengshu Ding, Hui Ding, Jingjing Zhang, Yingwei Cai, Hourong |
| ppnlink |
ELV00785823X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.intimp.2019.02.039 |
| up_date |
2024-07-06T19:48:00.392Z |
| _version_ |
1803860343934418944 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV046273611</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624122419.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.intimp.2019.02.039</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000607.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV046273611</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1567-5769(18)31455-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gui, Xianhua</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qiu, Xiaohua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tian, Yaqiong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xie, Miaomiao</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Hui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gao, Yujuan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhuang, Yi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cao, Mengshu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ding, Hui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ding, Jingjing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Yingwei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cai, Hourong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Laupland, Kevin B. ELSEVIER</subfield><subfield code="t">International immunopharmacology</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00785823X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:70</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:208-215</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.intimp.2019.02.039</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.75</subfield><subfield code="j">Infektionskrankheiten</subfield><subfield code="j">parasitäre Krankheiten</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">70</subfield><subfield code="j">2019</subfield><subfield code="h">208-215</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.4012156 |